OW, Hsia CCW. ␣Klotho deficiency in acute kidney injury contributes to lung damage. J Appl Physiol 120: 723-732, 2016. First published December 30, 2015 doi:10.1152/japplphysiol.00792.2015.-␣Klotho is a circulating protein that originates predominantly from the kidney and exerts cytoprotective effects in distant sites. We previously showed in rodents that the lung is particularly vulnerable to ␣Klotho deficiency. Because acute lung injury is a common and serious complication of acute kidney injury (AKI), we hypothesized that ␣Klotho deficiency in AKI contributes to lung injury. To test the hypothesis, we created AKI by renal artery ischemia-reperfusion in rats and observed the development of alveolar interstitial edema and increased pulmonary oxidative damage to DNA, protein, and lipids. Administration of ␣Klotho-containing conditioned media 6 h post-AKI did not alter plasma creatinine but improved recovery of endogenous ␣Klotho production 3 days post-AKI, reduced lung edema and oxidative damage, and increased endogenous antioxidative capacity in the lung. Intravenously injected ␣Klotho rapidly exits alveolar capillaries as a macromolecule, suggesting transcytosis and direct access to the epithelium. To explore the epithelial action of ␣Klotho, we simulated oxidative stress in vitro by adding hydrogen peroxide to cultured A549 lung epithelial cells. Purified recombinant ␣Klotho directly protected cells at 20 pM with half-maximal effects at 40-50 pM, which is compatible with circulating ␣Klotho levels. Addition of recombinant ␣Klotho activated an antioxidant response element reporter and increased the levels of target proteins of the nuclear factor erythroid-derived 2 related factor system. In summary, ␣Klotho deficiency in AKI contributes to acute lung injury by reducing endogenous antioxidative capacity and increasing oxidative damage in the lung. ␣Klotho replacement partially reversed these abnormalities and mitigated pulmonary complications in AKI. oxidative stress; total antioxidant capacity; cytoprotection; antioxidant response element; nuclear factor erythroid-derived 2 transcription factor.
tility, metabolic acidosis, and volume overload (26, 33, 34) can all contribute to respiratory failure and a high mortality. Independent from these septic and cardiovascular issues, there are tissue factors such as apoptosis, macrophage-derived mediators, chemokines, and ion channel derangements (12, 28, 29, 44) that have been implicated in the pathogenesis of alveolar hyperpermeability leading to the "inflamed, leaky, and wet" lung with low-pressure pulmonary edema. Patients with AKI develop significant functional impairment of diffusing capacity, forced vital capacity, and maximal ventilation (8, 10, 42, 47, 55) . The occurrence of ARDS requiring ventilator support drastically increases AKI mortality from 29% to 81% (6) . There is a dire need for strategies to protect the lung against secondary injury in the presence of extrapulmonary organ failure such as AKI.
The ␣Klotho gene was discovered when its serendipitous disruption led to premature multiorgan failure in mice (31) . ␣Klotho is a single-pass transmembrane protein produced predominantly by the kidney that functions as an obligate coreceptor for fibroblast growth factor 23, which is crucial for mineral metabolism (22) . The extracellular domain of ␣Klotho is released via cleavage by secretases into blood, urine, and cerebrospinal fluid as endocrine-soluble ␣Klotho (14, 24, 36) exerting multiple effects, including antioxidation, antiapoptosis, and antifibrosis, on distant organs (15, 22) . ␣Klotho is not normally expressed in the lung, but the alveolar capillary bed is constantly exposed to circulating ␣Klotho via perfusion by the entire cardiac output. Hemizygous genetic ␣Klotho haploinsufficient mice are normal in all organs at baseline except the lung, which exhibits age-exacerbated degenerative changes such as air space enlargement and increased compliance (46, 50) , suggesting particularly high sensitivity of the lung to ␣Klotho deficiency. We have shown that administration of conditioned media containing recombinant ␣Klotho protein protects the lung and lung epithelial cells against hyperoxic damage by increasing endogenous antioxidative capacity in vivo and in vitro (46) .
Because circulating soluble ␣Klotho originates mostly from the kidney, AKI is a state of transient systemic ␣Klotho deficiency (20, 43) . AKI per se is also a state of heightened systemic oxidative stress (40) . These observations beg the question of whether ␣Klotho deficiency in AKI contributes to the development of acute lung injury. We hypothesized that ␣Klotho deficiency is a mediator of pulmonary damage and dysfunction in AKI. To test this hypothesis, we used a rodent renal ischemia-reperfusion injury (IRI) model of AKI and its associated ␣Klotho deficiency to characterize and quantify lung injury. To investigate causality, we replenished serum ␣Klotho in AKI with exogenous ␣Klotho-containing condi-tioned medium and queried whether pulmonary abnormalities are alleviated. In addition, we visualized the in vivo transit of circulating ␣Klotho, a 130-kDa macromolecule, from the alveolar capillary to the interstitium and epithelium. Finally, we simulated oxidative stress in vitro by adding hydrogen peroxide (H 2 O 2 ) to cultured lung epithelial cells, and tested the antioxidative cytoprotective mechanisms of ␣Klotho cytoprotection.
METHODS

Animal Models
All animal experiments were conducted following the Guide for the Care and Use of Laboratory Animals by The National Institutes of Health. The Institutional Animal Care and Use Committee at University of Texas Southwestern approved all study protocols. An established IRI model was conducted as previously described (20) . Briefly, male Sprague-Dawley rats (250 -350 g) were housed in a 12:12-h light-dark cycle with free access to rodent chow and water. Under anesthesia, renal arteries were clamped with arterial clips (30 min), and occlusion was visually verified as blanching of the entire kidney surface. After clips were removed, the kidneys were observed for at least 5 min to ensure reperfusion. Control (Sham) animals underwent laparotomy of the same duration with manual manipulation of the kidneys without arterial clamping. At 3 days following surgery, blood was drawn and stored at Ϫ80°C for further processing. Plasma and urine chemistry was analyzed using a Vitros Chemistry Analyzer (Ortho-Clinical Diagnosis, Rochester, NY). Serum ␣Klotho concentration was measured by immunoprecipitation-immunoblot (1) .
To examine the effects of ␣Klotho replacement in AKI, the rats received intraperitoneal injections of either control medium (100 l), or ␣Klotho-containing conditioned medium (100 l, ϳ60 -100 pM, n ϭ 8) 6 h after induction of IRI (see Conditioned ␣Klotho-Containing Medium and Recombinant Soluble ␣Klotho for preparation of conditioned medium). Seven to eight animals per group were used. Three days after IRI, rats were killed by intraperitoneal overdose injection of Euthasol. The left lung was perfused with sterile PBS and snap-frozen in liquid nitrogen for the assays described later. The right lung was fixed by intratracheal instillation of 4% paraformaldehyde at a constant airway pressure (25 cmH 2O). Tissue blocks from the right caudal lobe were sampled, embedded in paraffin, sectioned (4 m) and stained (trichrome) for histological evaluation.
For immunohistochemistry, lung sections were incubated with anti-FLAG antibody (Sigma-Aldrich, St. Louis, MO) for FLAG␣Klotho, Oregon Green 488 phalloidin (Invitrogen, Carlsbad, CA) for actin, and CD31 antibody (Abcam, Cambridge, U.K.) to outline the endothelium. The sections were incubated with the appropriate secondary antibodies: Alexa fluor 555 (red; FLAG-␣Klotho), Alexa fluor 488 (green; CD31), and SYTO 61 (red converted to blue pseudocolor for nuclei; Invitrogen).
To determine whether circulating ␣Klotho directly reaches alveolar epithelium or acts via other mechanisms on the epithelium, we visualized the fate of intravenously injected FLAG-tagged ␣Klotho. Three normal C57/BL6 mice were anesthetized with intraperitoneal ketamine (100 mg/kg body wt) and xylazine (10 mg/kg). Through a transverse neck incision (ϳ0.5 cm), the trachea was cannulated, the right jugular vein was isolated, and a silastic catheter filled with heparinized saline was introduced into the vessel. Recombinant ␣Klotho (4 nmol) was injected, and, after a predetermined time, the lung was fixed by tracheal instillation of 4% paraformaldehyde at 25 cmH2O pressure. Two control mice received injection of vehicle (saline).
Conditioned ␣Klotho-Containing Medium and Recombinant Soluble ␣Klotho
Two types of ␣Klotho preparations were used. Conditioned media containing ␣Klotho were prepared as previously described (46) for use in animal experiments. Briefly, Chinese hamster ovary (CHO) cells were stably transfected with soluble ␣Klotho or empty vector. Serum-free DMEM was added 16 h posttransfection and, after another 16 h, media were collected and stored at Ϫ80°C until further processing. The conditioned medium contains recombinant soluble ␣Klotho along with other secreted proteins from the CHO cells. The control media were obtained from CHO cells transfected with only the expression plasmid.
Purified recombinant ␣Klotho was used in ␣Klotho tracking and in cell culture experiments. Murine soluble ␣Klotho was cloned into pEF1/Myc-His/A vector (Invitrogen) and transfected into suspension of Free-Style 293-F cells (Invitrogen). To establish stable cell lines that expressed recombinant protein, cells were selected in 500 g/ml G418 (Gibco, Grand Island, NY). Single clones of stable ␣Klotho-expressing cells were cultured in serum-free medium (Invitrogen) with 100 g/ml G418 and 10% Pluronic F-68. The condition media were collected at suspension cell density ϳ300 ϫ 10 4 and centrifuged at 15,000 g for 30 min at 4°C to remove cell debris. The supernatant was mixed with Ni-NTA resin (Thermo, Waltham, MA) that was pre-equilibrated with 20 mM phosphate, pH 7.4, 300 mM NaCl. After incubation at 1 h at room temperature, the Ni-NTA resin was packed into the Econo column and washed with the above buffer (35ϫ column volume). Bound ␣Klotho was eluted by 50 -250 mM imidazole. The highest concentration ␣Klotho protein was eluted at the second fraction by 50 mM imidazole. ␣Klotho protein quality was checked by SDS-PAGE, Coomassie blue staining of a single band, and immunoblot with specific ␣Klotho antibodies (data not shown).
Lung Edema Estimation (Na ϩ to Dry Lung Weight Ratio)
Lung tissue (ϳ100 mg) was weighed and transferred to a platinum ashing crucible and placed on a hot plate set at 100°C under a heat lamp for 2 h. The dried-sample-containing crucible was weighed to determine the sample dry weight. The crucible was placed overnight in the ash oven set at 600°C, removed, and weighed to determine the ash weight. The ash was dissolved in 2 ml of HCl, and the Na ϩ content was measured by flame photometry.
Cell Culture
Human A549 lung epithelial cells (American Type Culture Collection, Manassas, VA) were grown in DMEM-nutrient mixture F12 (Life Technologies, Grand Island, NY) with 1% L-glutamine. An in vitro oxidative stress model using H 2O2, modified from one employed by Panesso et al. (43) in kidney cells, was used to study the cytoprotective effects of ␣Klotho. Triplicate experiments and assays were performed.
Biochemical Assays
Cell injury. A lactate dehydrogenase (LDH) cytotoxicity detection kit (Clontech Laboratories, Mountain View, CA) was used to measure release of cytoplasmic LDH into the culture supernatant. LDH generates NADH from lactate, which reacts with diaphorase to generate formazan dye products (absorbance 490 nm).
Total antioxidant capacity. Both copper-and iron-based assays were performed. Copper-reducing equivalents were measured using a calorimetric assay (OxiSelect; Cell BioLabs, San Diego, CA). The Trolox antioxidant assay (Sigma-Aldrich) is based on formation of a ferryl myoglobin radical from metmyoglobin and H 2O2, which oxidizes 2,2=-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) to generate the ABTS .ϩ radical cation, a soluble chromogen (absorbance 405 nm). Trolox, a water-soluble vitamin E analog, serves as a standard control antioxidant.
␣Klotho Deficiency, Acute Kidney Injury, and Lung Damage • Ravikumar P et al. Antioxidant reporter. A dual-luciferase assay (Cignal; SA Biosciences, Valencia, CA) was used to measure the activity of Nrf-1 and -2 (nuclear factor E2-related factors 1 and 2) transcription factor activation of tandem antioxidant response element (ARE) regulating genes that protect cells from oxidative damage. The ARE reporter contains an inducible antioxidant responsive firefly luciferase construct and a constitutively expressed Renilla luciferase construct. Upon transfection with the ARE reporter, the activities of the firefly and Renilla luciferases quantify transcriptional activities of the antioxidant response pathway.
Oxidative damage. 8-Hydroxydeoxyguanosine (8-OHdG) was used as a marker of oxidative DNA injury. DNA was extracted using DNAzol (Life Technologies), precipitated in 100% ethanol, washed with 70% ethanol, and suspended in 8 mM NaOH, and the 8-OHdG concentration was determined by ELISA (OxiSelect; Cell BioLabs) compared against a 8-OHdG standard curve. Protein carbonyl was measured by ELISA (OxiSelect; Cell BioLabs) as a surrogate for protein oxidation against a known reduced/oxidized BSA standard curve. 8-Isoprostane was measured by enzyme immunoassay (Cayman Chemical, Ann Arbor, MI) as a marker for lipid oxidation, based on the competitive binding between 8-isoprostane and an 8-isoprostane acetylcholinesterase conjugate (8-isoprostane tracer) for limited specific binding sites.
Immunoblot. Whole cell lysates from A549 cells after treatment were prepared using RIPA buffer (150 mM NaCl, 50 mM Tris·HCl, pH 7.4, 5 mM EDTA, 1% Triton X-100, 0.5% deoxycholate, and 0.1% SDS) containing fresh phosphatase and protease inhibitors and cleared by centrifugation (14,000 g, 4°C, 30 min), and protein content was determined by the method of Bradford. Protein samples (30 g) were loaded onto SDS-PAGE and electrophoretically transferred to polyvinylidene difluoride (PVDF) membranes. After blocking in 5% nonfat milk, PVDF membranes were probed with primary antibodies against MT (Metallothionein, Santa Cruz Biotechnology, San Diego, CA, sc-11377, 1:500), HOX1 (Heme Oxygenase 1, Abcam, Cambridge, MA, ab13248, 1:500), HOX2 (Heme Oxygenase 2, Abcam, ab90492, 1:1000), and PXDN (Peroxidasin homolog, Abcam, Fig. 1 . ␣Klotho deficiency and repletion in acute kidney injury (AKI). Sprague-Dawley rats underwent bilateral ischemia-reperfusion injury (IRI), and lungs were harvested 3 days later. The control group underwent general anesthesia and laparotomy with manual manipulation of the kidneys but without IRI (Sham). Rats received intraperitoneal injection of either ␣Klotho-containing or control conditioned media 6 h after surgery. A: severity of AKI was measured by serum creatinine level in the animals 3 days after IRI. B: serum ␣Klotho level was measured by immunoprecipitation-immunoblot 3 days after IRI at the time of lung harvest. Representative blots are shown. IgG-HC, immunoglobulin heavy chain. C: representative lung histology (Trichrome stain). D: Na ϩ to dry weight ratio as a measure of interstitial edema. Means Ϯ SD (n ϭ 7-8 animals per group). Statistical significance was assessed by ANOVA. ab179663, 1:500) overnight at 4°C followed by secondary antibodies conjugated with horseradish peroxidase. Specific signal was visualized by enhanced chemiluminescence (Amersham Life Sciences, Pittsburgh, PA) and quantified by densitometry using ImageQuant.
Data Analysis
Measurements from seven to eight animals per group and triplicate independent assays or in vitro experiments were expressed as means Ϯ SD. Statistical analysis used factorial ANOVA with a post hoc Fisher's protected least-significant difference test, and P Ͻ 0.05 was considered significant.
RESULTS
Acute Lung Injury in AKI
The established model of renal ischemia-reperfusion injury markedly increased serum creatinine, which typically peaks at five to eight times normal control levels at 1-2 days as reported by Hu et al. (20) , then declined to two to three times control levels by Day 3 (Fig. 1A) , and reduced circulating ␣Klotho levels by ϳ60% (Fig. 1B) . In this AKI setting, lung histology showed small crowded distal air spaces, thicker alveolar walls, and cellular exudation into the air spaces (Fig. 1C) . The Na ϩ to dry lung weight ratio was elevated, indicating tissue edema (Fig. 1D) . The lungs from AKI animals showed generalized oxidative damage of DNA, protein, and lipids compared with control (sham AKI) lungs ( Fig. 2A) , which is consistent with heightened oxidative stress to the lungs in AKI in a manner similar to that previously described by Ravikumar et al. (46) in direct lung injury caused by acute hyperoxia exposure. Total antioxidant capacity measured by copper-reducing equivalents and Trolox (a water-soluble vitamin E analog) equivalent assays showed diminished antioxidant capacity with AKI. These results show an association between circulating ␣Klotho deficiency in AKI and lung damage, which may reflect depletion of endogenous antioxidants in AKI (Fig. 2B) .
Role of ␣Klotho in Lung Protection
␣Klotho replacement given before or within 1 h after IRI alleviates AKI and accelerates recovery (20) , but ␣Klotho repletion given 4 h or later post-IRI does not affect the peak plasma creatinine (vehicle vs. ␣Klotho-treated in AKI in a separate cohort of 3 animals each: Day 1: 1.35 Ϯ 0.17 vs. 1.27 Ϯ 0.09 mg/dl; Day 2: 1.25 Ϯ 0.26 vs. 1.13 Ϯ 0.15 mg/dl, means Ϯ SD). Therefore, in this study, by administering ␣Klotho 6 h after AKI induction by IRI, we did not change the course of AKI as defined by serum creatinine levels on Day 3 of AKI that were similar to that in the untreated group (Fig.  1A) . However, exogenous ␣Klotho administration improved serum endogenous ␣Klotho levels 3 days after AKI (Fig. 1B) . The higher ␣Klotho levels 3 days post-IRI are unlikely to be attributed to the exogenous ␣Klotho, because the half-life of ␣Klotho even in the complete anephric state is only 24 h (21); rather, this observation reflects improved endogenous ␣Klotho production. Exogenous ␣Klotho also increases native renal ␣Klotho expression after two forms of AKI including bilateral IRI (48) .
Exogenous ␣Klotho administration significantly ameliorated alveolar septal crowding and exudation of cells and debris into the air space (Fig. 1B) ; alveolar edema (Fig. 1C) ; and oxidative damage to DNA, protein, and lipids in the lungs of animals with AKI ( Fig. 2A) . The reduction of oxidative damage with ␣Klotho repletion was associated with a higher endogenous oxidative capacity measured by two independent assays (Fig. 2B) . These effects occurred with no change in serum creatinine (Fig. 1A) , thus dissociating the benefit on the lung from the improvement of renal function by ␣Klotho. In control (sham) animals, exogenous ␣Klotho modestly increased total antioxidant capacity measured by copper-reducing equivalents but had no effect on Trolox total antioxidant capacity or any of the oxidative damage parameters. These interventional data strongly sup- Fig. 2 . Acute lung injury in AKI. SpragueDawley rats underwent bilateral IRI and lungs were harvested 3 days later. The control group underwent general anesthesia and laparotomy with manual manipulation of the kidneys but without IRI (Sham). Rats received intraperitoneal injection with either ␣Klotho-containing or control conditioned media 6 h after surgery, and lungs were harvested 3 days later. A: markers of DNA (8-hydroxy-2=-deoxyguanosine; 8OHdG), protein (protein carbonyl), and lipid (8-isoprosane) oxidative damage. B: markers for endogenous antioxidative capacity were assessed by a Cu-based (left) or a Fe-based (right) assay. Bars and error bars are mean and SD (n ϭ 7-8 animals per group). Statistical significance was assessed by ANOVA.
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Circulating ␣Klotho Can Directly Access Pulmonary Epithelial Cells
While the animal experiments offer important proof-ofprinciple data that ␣Klotho deficiency exacerbates and ␣Klotho repletion ameliorates lung injury, the complexities of the intact organism preclude examination of the direct actions of ␣Klotho on pulmonary epithelia. To understand the mechanisms of ␣Klotho cytoprotection, we first tracked whether this 130-kDa macromolecule can exit the pulmonary vasculature to access the alveolar epithelium. In the kidney it is known that ␣Klotho cannot traverse the glomerular capillary, but it can selectively cross the peritubular capillary freely, to be taken up by the tubular cells in a surprisingly short time (21) . To test whether rapid transport occurs in pulmonary capillaries, we injected FLAG-tagged ␣Klotho intravenously in mice. Within 20 -30 min after injection, the FLAG label was seen inside alveolar capillaries (Fig. 3, A and B) , and also clearly detectable in the septal interstitial space with extracapillary cellular uptake, including possibly by alveolar type II cells (Fig. 3B) . Thus circulating ␣Klotho can rapidly exit the capillary to access and directly act on the alveolar epithelium.
Cytoprotection by ␣Klotho via Antioxidation
To examine whether ␣Klotho ameliorates cellular oxidative damage, H 2 O 2 was added to cultured A549 human lung epithelial cells to simulate the post-AKI milieu of oxidative stress. We observed that H 2 O 2 induced cellular damage measured by LDH release in a dose-dependent fashion (Fig.  4A) . We chose a H 2 O 2 concentration of 200 nM to induce moderate oxidative stress with measurable cell harm to enable the evaluation of cytoprotection. Previously, we found that ␣Klotho transfection and the addition of ␣Klotho-conditioned media prevented A549 cell death from hyperoxic insult (46) , but that system did not permit deter- Fig. 3 . Tracking soluble ␣Klotho transfer in the lung. COOH-terminal FLAG-tagged purified recombinant ␣Klotho (4 nmol in 200 ml) was injected intravenously into 3 normal C57/ BL6 mice, and the lungs were harvested 20 -30 min after injection. Two control mice received injection of vehicle (saline). Exogenous ␣Klotho was stained with anti-FLAG antibody. A: 20 min after injection with FLAG-␣Klotho or vehicle. Representative images of FLAG-␣Klotho (anti-FLAG with Alexa fluor 555-coupled secondary antibody; red), ␤-actin (Oregon Green 488-coupled phalloidin; green), and nuclei (SYTO 61; red digitally converted to blue) are shown. B: 30 min after injection with FLAG-␣Klotho. Representative images of FLAG-␣Klotho (anti-FLAG with Alexa fluor 555-coupled secondary antibody; red), endothelium (anti-CD31 with Alexa fluor 488-coupled secondary antibody; green), and nuclei (SYTO 61; red digitally converted to blue) are shown. Arrows, localization of FLAG-␣Klotho: intracapillary (1); interstitium (2); and epithelium (3), possibly an alveolar type 2 cell. ␣Klotho Deficiency, Acute Kidney Injury, and Lung Damage • Ravikumar P et al. mination of the ␣Klotho concentration required for cytoprotection and whether it is comparable to the circulating ␣Klotho concentration. Here we used purified recombinant ␣Klotho protein to define the dose range of ␣Klotho required for cytoprotection. A decline in H 2 O 2 -induced LDH release was detectable at a ␣Klotho concentration of 25 pM, and maximal response was attained at ϳ200 pM (Fig. 4B) . The range where cytoprotective efficacy is observed is in the same order of magnitude as the circulating ␣Klotho concentration in humans and rodents (1, 21) . Consistent with its effect on LDH release, ␣Klotho addition ameliorated the increase in oxidative damage to DNA, protein, and lipids in a dose-dependent fashion in A549 cells exposed to H 2 O 2 (Fig. 5, A-C) .
␣Klotho-conditioned media contain many cell-derived substances that can potentially activate the Nrf2 pathway (46). Here we used purified recombinant ␣Klotho to show that it activates Nrf2 in a dose-dependent fashion in A549 cells challenged with H 2 O 2 (Fig. 6A) . We screened an array of downstream effectors of Nrf2 and found that ␣Klotho increased the protein levels of methalothionine (MTA), hemeoxygenase 1 and 2 (HOX1 and HOX2), and peroxidasin (PXDN; Fig. 6B ).
DISCUSSION
Summary of the Rationale and Major Findings
This is the first report to examine the role of ␣Klotho in acute lung injury resulting from extrapulmonary organ failure. We previously showed that the lung exhibits heightened oxidative damage in mice with genetic ␣Klotho insufficiency and that exogenous ␣Klotho-containing conditioned media protect the lung against hyperoxia-induced acute damage; protection is at least partly mediated via increasing endogenous antioxidant capacity (46) . We also previously showed that the rodent IRI model of AKI represents a state of acute systemic ␣Klotho deficiency (20) , while the reperfusion phase post-renal ischemia is a state of high oxidative stress (51) . Thus the AKI model represents double oxidative insults on the lung and provides the rationale for our hypothesis that the acute ␣Klotho deficiency in AKI contributes to lung damage.
Our findings support the following hypothesis: 1) acute lung injury characterized by interstitial edema and tissue oxidative damage is detectable in this rodent model of endogenous ␣Klotho deficiency caused by AKI; 2) repletion of ␣Klotho 6 h post-AKI does not alter the severity of AKI as measured by serum creatinine levels but significantly reduces the severity of acute lung injury; 3) circulating ␣Klotho exits the alveolar microvasculature rapidly to reach the alveolar interstitium and epithelium; and 4) ␣Klotho directly alleviates oxidative damage of pulmonary epithelia in cell culture by augmenting endogenous antioxidative capacity at least partly via activation of Nrf2 effectors. In concert, these findings support the notion that endogenous ␣Klotho deficiency in AKI contributes to development of acute lung injury and suggest the potential for therapeutic replacement.
Cytoprotection by ␣Klotho
␣Klotho is the first member of the three-member KLOTHO gene family (22) . ␣Klotho was touted as an antiaging protein due to the premature multiorgan failure that results from its serendipitous disruption (31) and the life span extension by its ectopic overexpression (32) . The extracellular domain of ␣Klotho is proteolytically cleaved and released into the circulation, cerebrospinal fluid, and urine (4, 5, 18, 24) , and exerts a wide array of effects on many target organs (15, 22) . The kidney expresses the highest level of ␣Klotho, and the circulating (soluble) ␣Klotho comes primarily from the kidney (21, 35) . It is not surprising that circulating levels of ␣Klotho plummets in AKI, with trough levels usually reached around Day 1 (20, 21, 43) . The potential diagnostic, prognostic, and ␣Klotho Deficiency, Acute Kidney Injury, and Lung Damage • Ravikumar P et al. therapeutic role of ␣Klotho in AKI has been summarized elsewhere (16) . In general the cytoprotective effects of Klotho have been attributed to its antiapoptotic, antifibrotic, and antioxidative properties (22, 30) .
Pulmonary Involvement and Mechanisms of Acute Lung Injury in AKI
Pulmonary impairment in AKI is usually attributed to extrapulmonary factors such as sepsis, cardiac dysfunction, volume overload, and metabolic acidosis (8, 10, 42, 55) . Of the twelve comorbid variables examined in one study, severe pulmonary involvement requiring mechanical ventilation conferred the worst prognosis elevating mortality from 29% to 81% even after multivariate adjustment (6). Because current treatment modalities for AKI cannot alter the natural course of kidney injury, the prevention or mitigation of complications associated with AKI should be prime therapeutic targets, as they will likely improve clinical outcomes. The possibility that AKI depletes a natural cytoprotective factor thereby predisposing to lung injury had not been examined.
The mechanism of acute lung injury in AKI is complex and multifactorial. ␣Klotho deficiency is one potentially important pathogenic factor. Circumstantial observations prompted us to formulate the following hypothesis that ␣Klotho deficiency contributes to pulmonary dysfunction in AKI: 1) AKI is accompanied by systemic ␣Klotho deficiency in rodents (20, 43) ; 2) AKI is a state of heightened oxidative stress (51); 3) the lung is particularly susceptible to ␣Klotho deficiency and relies on ␣Klotho to maintain its native antioxidative capacity (46); and 4) ␣Klotho is protective against oxidative stress in general (30) . Unlike most organs that manifest no pathology at baseline in heterozygous hypomorphic ␣Klotho haplo-insufficient mice, the lungs show age-related morphological abnormalities and increased oxidative DNA damage when the circulating ␣Klotho level is ϳ50% of normal (46) . If one lowers the circulating ␣Klotho level further and contemporaneously increases the oxidative stress challenge such as in AKI, it is conceivable that the lungs would be rendered even more susceptible to damage. Using an interventional approach, we showed that post-AKI restoration of circulating ␣Klotho levels partially reversed the lung damage without altering peak AKI severity. These results support our hypothesis.
Mechanisms of ␣Klotho Protection in the Lung
The finding of partial reversal of lung damage by repletion of circulating ␣Klotho agrees with earlier findings where ␣Klotho prevents and ameliorates ischemic and nephrotoxic kidney damage (17, 20, 43) . Soluble ␣Klotho functions as an endocrine substance, although a cognate receptor in its target organs has not been identified. One enigma is how this 130-kDa protein transits through the vasculature and reaches its targets. In AKI, pulmonary capillaries are leaky (2, 28) , which can theoretically enhance the exit of macromolecules, but circulating levels of ␣Klotho are low in AKI (20) so increased permeability alone will not suffice. In the kidney, exogenously injected ␣Klotho crosses the peritubular capillary readily and reaches the urinary tubular lumen via tandem transcytosis across the peritubular capillary and tubular epithelium, but ␣Klotho does not traverse the glomerular capillary, indicating selective permeability and suggesting differential endothelial transcytosis (21) . Now we demonstrate that ␣Klotho exits the pulmonary capillary to reach the interstitium and alveolar ␣Klotho Deficiency, Acute Kidney Injury, and Lung Damage • Ravikumar P et al. epithelium. The transport of this large protein across the capillary may occur via caveolae-or clathrin-mediated endocytosis in the capillaries (27, 37, 49) or via vesicular vacuolar organelles toward the venules (9, 11); elucidating these mechanisms will require further investigation.
We previously showed that transfection of either the transmembrane or the extracellular domain of ␣Klotho increases the endogenous antioxidative capacity of cultured human alveolar type I epithelial cells and A549 lung cell lines (46) . Transfection does not replicate the in vivo exposure to circulating ␣Klotho or allow examination of dose-response relationships. Therefore, we synthesized, purified, and added recombinant ␣Klotho to cultured A549 cells to test the direct effects conferred by ␣Klotho and to establish a dose response of ␣Klotho action. Purified ␣Klotho exerts protection in concentrations compatible with its circulating levels, although we do not know the interstitial ␣Klotho concentration in the lung. A single injection of recombinant ␣Klotho, albeit at a pharmacologic concentration, led rapidly to detectable levels in the pulmonary interstitium. The clearance of ␣Klotho from the circulation is largely via the kidneys (21) , but the mechanism of ␣Klotho clearance from tissue is unclear. It is conceivable that there may be accumulation of ␣Klotho in the lung interstitium to levels higher than that in plasma.
The Cap and Collar family of transcription factors comprises four related factors: Nrf1, Nrf2, Nrf3, and p45 NF-E2 (3). Nrf1 is important for counteracting steady-state stress under basal homeostatic states while Nrf2 is crucial for maintaining cell health in response to severe stressors such as reactive oxygen species, inflammatory cytokines, and endoplasmic reticulum stress (7, 41, 53) . The ARE binds to Nrf2 and small Maf proteins. The small Maf proteins, originally described in musculoaponeurotic fibrosarcoma, are leucine zipper-containing transcriptional cofactors that function cooperatively with Nrf2 in vivo (38) . The AREs are found in the transcriptional regulatory regions of many antioxidant and xenobiotic-metabolizing enzyme genes (3, 39) and are thought to account for the concerted upregulation of these genes during oxidative stress. Several lines of evidence support antioxidation via the Nrf2 pathway as a mechanism underlying ␣Klotho cytoprotection. The stimulation of many antioxidant and detoxification enzyme genes is severely impaired in Nrf2-null mutant mice (25) , while ␣Klotho-overexpressing mice are more resistant to paraquat-induced oxidative stress (54) . ␣Klotho overexpression drives Nrf2 localization to the nucleus in cells (13) . Pretreatment of hippocampal neurons with recombinant ␣Klotho increases expression of the thioredoxin/peroxiredoxin system (56), which is a known downstream effector of the Nrf2 pathway (52) . Our findings of increased expression of antioxidant targets of the Nrf2 pathway (MTA, HOX1, HOX2, and PXDN) following ␣Klotho administration in AKI are consistent with this mechanism of action. In addition to Nrf2, ␣Klotho also activates the FoxO family of transcriptional factors and induces superoxide dismutase 2 (SOD2) expression (23, 54) , and ␣Klotho-containing conditioned media increase SOD2 expression and nitric oxide production in human umbilical vein endothelial cells (45) . Additional mechanisms of ␣Klotho action such as antiapoptosis may also play a role.
In conclusion, acute lung injury is a life-threatening complication in AKI that significantly escalates morbidity and mortality (6) . The pathogenesis of acute lung injury in AKI involves diverse multisystem interactions including cardiac, extracellular fluid volume, metabolic, cytokine, and sometimes sepsis-related factors. We provide evidence that ␣Klotho secreted from the kidney into the circulation reaches and directly acts on the alveolar epithelia, and its deficiency in AKI is an important contributing factor to the loss of endogenous antioxidative capacity of the pulmonary epithelium. The diminished ␣Klotho-mediated antioxidative cytoprotection occurs in a setting of heightened oxidative stress, which can compound and amplify the deleterious effects of all the other pathogenic intermediates that contribute to the development of lung injury and ARDS in the setting of AKI. These data suggest that prevention or amelioration of lung damage by ␣Klotho replacement holds substantial promise as a therapeutic intervention in AKI to prevent or mitigate secondary pulmonary complications. While ␣Klotho replacement reduced lung damage in the absence of an improvement in serum creatinine, endogenous ␣Klotho production also improved. Thus the observed cytoprotective effects of ␣Klotho arose from a combination of direct pulmonary and indirect systemic actions. 
